OncoCyte Corp (OCX)
2.66
-0.01
(-0.37%)
USD |
NASDAQ |
Nov 22, 11:26
OncoCyte Profit Margin (Quarterly): -11.73K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.73K% |
| June 30, 2024 | -4.36K% |
| March 31, 2024 | -5.19K% |
| December 31, 2023 | -5.09K% |
| September 30, 2023 | -1.51K% |
| June 30, 2023 | -1.80K% |
| March 31, 2023 | |
| December 31, 2022 | -16.42K% |
| September 30, 2022 | -13.93K% |
| June 30, 2022 | -3.50K% |
| Date | Value |
|---|---|
| March 31, 2022 | -2.71K% |
| December 31, 2021 | |
| September 30, 2021 | -1.40K% |
| June 30, 2021 | -516.9% |
| March 31, 2021 | -348.7% |
| December 31, 2020 | -1.25K% |
| September 30, 2020 | -1.22K% |
| June 30, 2020 | -6.37K% |
| March 31, 2020 | -48.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-48.32K%
Minimum
Mar 2020
-348.7%
Maximum
Mar 2021
-7.39K%
Average
-3.50K%
Median
Jun 2022
Profit Margin (Quarterly) Benchmarks
| Fonar Corp | 12.56% |
| XWELL Inc | -56.40% |
| ProPhase Labs Inc | -209.4% |
| Applied DNA Sciences Inc | -- |
| Veracyte Inc | 13.08% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -211.4% |
| Return on Assets | -57.93% |
| Return on Invested Capital | -211.4% |
| Gross Profit Margin (Quarterly) | 43.48% |
| Operating Margin (Quarterly) | -5.54K% |
| Return on Net Operating Assets | -68.41% |